stockportfolio.pro
ACADIA Pharmaceuticals Inc. Shares Outstanding 2009–2025
ACADIA Pharmaceuticals Inc. (ACAD) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 170.3M | +2.2% |
| FY 2024 | 166.7M | +1.3% |
| FY 2023 | 164.7M | +1.6% |
| FY 2022 | 162.1M | +0.7% |
| FY 2021 | 161.0M | +0.9% |
| FY 2020 | 159.6M | +2.8% |
| FY 2019 | 155.3M | +7.9% |
| FY 2018 | 143.9M | +15.6% |
| FY 2017 | 124.4M | +2.5% |
| FY 2016 | 121.4M | +19.1% |
| FY 2015 | 101.9M | +1.9% |
| FY 2014 | 100.0M | +9.8% |
| FY 2013 | 91.1M | +24.2% |
| FY 2012 | 73.3M | +38.6% |
| FY 2011 | 52.9M | +34.4% |
| FY 2010 | 39.4M | — |
| FY 2009 | 0.0M | — |
Source: ACADIA Pharmaceuticals Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for ACADIA Pharmaceuticals Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeACADIA Pharmaceuticals Inc. — frequently asked questions
What is ACADIA Pharmaceuticals Inc.'s shares outstanding?
ACADIA Pharmaceuticals Inc. (ACAD) reported shares outstanding of 170.3M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.